Postdoctoral Fellow | City of Hope National Medical Center | United States
Dr. Imran Shair Mohammad is a distinguished pharmaceutical scientist whose research focuses on developing next-generation minimally invasive cancer immunotherapies through the design of innovative drug delivery systems and biomaterials. His work lies at the intersection of drug discovery, mRNA and peptide engineering, and biomaterial science, with an emphasis on creating nano/microparticle and hydrogel-based systems for targeted delivery of exosomes, RNA, peptides, and small molecules to improve therapeutic outcomes in cancer, inflammation, and infectious diseases. He earned his Ph.D. in Pharmaceutics from China Pharmaceutical University, Nanjing, following an M.Phil and Pharm.D. from The Islamia University of Bahawalpur, Pakistan. Professionally, Dr. Mohammad has held several postdoctoral research positions across leading international institutions, including the University of North Carolina at Chapel Hill, Erciyes University in Turkey, Sun Yat-sen University in China, and currently serves at the City of Hope National Medical Center, USA. His expertise spans drug and gene delivery, mRNA and peptide synthesis, protein engineering, and immunomodulatory biomaterials, with hands-on proficiency in nanoparticle development, polymer chemistry, and advanced analytical techniques such as HPLC, TEM, and LC-MS. His research interests encompass cancer immunotherapy, drug resistance, cellular engineering, and microbiome-based therapeutics. Dr. Mohammad has published over 40 peer-reviewed articles, received multiple international research grants from the USA, Turkey, and China, and serves on the editorial boards of Cancer Immunology Connect and Current Drug Delivery. Recognized with prestigious honors such as the High-Level Foreign Talents Award from Guangdong Province and the Chinese Government Ph.D. Scholarship, he continues to contribute to advancing translational nanomedicine and targeted immunotherapeutic strategies. His career exemplifies a commitment to scientific innovation, interdisciplinary collaboration, and impactful research that bridges laboratory discoveries with clinical applications for global health advancement.
Profiles: Google Scholar | Scopus | ORCID | ResearchGate | LinkedIn
Featured Publications
1. Mohammad, I. S., He, W., & Yin, L. (2018). Understanding of human ATP binding cassette superfamily and novel multidrug resistance modulators to overcome MDR. Biomedicine & Pharmacotherapy, 100, 335–348. https://doi.org/10.1016/j.biopha.2018.02.028 Cited by: 226
2. Mohammad, I. S., Hu, H., Yin, L., & He, W. (2019). Drug nanocrystals: Fabrication methods and promising therapeutic applications. International Journal of Pharmaceutics, 562, 187–202. https://doi.org/10.1016/j.ijpharm.2019.03.055 Cited by: 163
3. Ishaq, H. M., Mohammad, I. S., Guo, H., Shahzad, M., Hou, Y. J., Ma, C., Naseem, Z., … (2017). Molecular estimation of alteration in intestinal microbial composition in Hashimoto’s thyroiditis patients. Biomedicine & Pharmacotherapy, 95, 865–874. https://doi.org/10.1016/j.biopha.2017.08.097 Cited by: 134
4. Wang, X., Mohammad, I. S., Fan, L., Zhao, Z., Nurunnabi, M., Sallam, M. A., Wu, J., … (2021). Delivery strategies of amphotericin B for invasive fungal infections. Acta Pharmaceutica Sinica B, 11(8), 2585–2604. https://doi.org/10.1016/j.apsb.2021.03.013 Cited by: 130
5. Gu, Y., Mohammad, I. S., & Liu, Z. (2020). Overview of the STAT-3 signaling pathway in cancer and the development of specific inhibitors. Oncology Letters, 19(4), 2585–2594. https://doi.org/10.3892/ol.2020.11309 Cited by: 120
